3,178
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Halloysites modified polyethylene glycol diacrylate/thiolated chitosan double network hydrogel combined with BMP-2 for rat skull regeneration

, , ORCID Icon, &
Pages 71-82 | Received 23 Oct 2019, Accepted 27 Nov 2020, Published online: 11 Jan 2021

Figures & data

Figure 1. (A) FTIR spectra, (B) zeta potential of HNTs and T-HNTs; SEM images of (C) HNTs and (D) T-HNTs.

Figure 1. (A) FTIR spectra, (B) zeta potential of HNTs and T-HNTs; SEM images of (C) HNTs and (D) T-HNTs.

Figure 2. (A) Scheme for the fabrication of PEGDA/TCS/T-HNTs composite hydrogels, (B) schematic of hydrogel compression: (a) before compression, (b) processing of compression and (c) after compression.

Figure 2. (A) Scheme for the fabrication of PEGDA/TCS/T-HNTs composite hydrogels, (B) schematic of hydrogel compression: (a) before compression, (b) processing of compression and (c) after compression.

Figure 3. The typical (A) tensile and (B) compression stress-strain curves of PEGDA/TCS and PEGDA/TCS/T-HNTs with different contents of T-HNTs composite hydrogel, (C) the cyclic compressive stress-strain curves of PEGDA/TCS and PEGDA/TCS/T-HNTs-1.5 hydrogel at 70% strain, the rheological results of PEGDA/TCS and PEGDA/TCS/T-HNTs-1.5 hydrogels: (D) time sweeping of storage modulus (G′) and loss modulus (G′′) under a 50 mW/cm2 UV condition, (E) frequency-dependent (at a strain of 1%) and (F) strain-dependent (ω = 6.28 rad/s) oscillatory shear.

Figure 3. The typical (A) tensile and (B) compression stress-strain curves of PEGDA/TCS and PEGDA/TCS/T-HNTs with different contents of T-HNTs composite hydrogel, (C) the cyclic compressive stress-strain curves of PEGDA/TCS and PEGDA/TCS/T-HNTs-1.5 hydrogel at 70% strain, the rheological results of PEGDA/TCS and PEGDA/TCS/T-HNTs-1.5 hydrogels: (D) time sweeping of storage modulus (G′) and loss modulus (G′′) under a 50 mW/cm2 UV condition, (E) frequency-dependent (at a strain of 1%) and (F) strain-dependent (ω = 6.28 rad/s) oscillatory shear.

Figure 4. SEM images of (A) PEGDA/TCS and PEGDA/TCS/T-HNTs hydrogels with different contents of T-HNTs: (B) 0.5, (C) 1.0, (D) 1.5 and (E) 2.0 composite, (F) the corresponding swelling ratio of hydrogels.

Figure 4. SEM images of (A) PEGDA/TCS and PEGDA/TCS/T-HNTs hydrogels with different contents of T-HNTs: (B) 0.5, (C) 1.0, (D) 1.5 and (E) 2.0 composite, (F) the corresponding swelling ratio of hydrogels.

Figure 5. (A) CLSM micrographs of stained MC3T3-E1 cells showing morphology adhered on PEGDA/TCS, PEGDA/TCS/HNTs and PEGDA/TCS/T-HNTs hydrogels after 1, 3, and 7 days of culture (cytoskeleton and nucleus were stained with rhodamine-conjugated phalloidin (red) and DAPI (blue), respectively, and the scale bar is 50 µm); (B) the corresponding results of MC3T3-E1 cells. The values are represented as mean ± SD (n = 6). *p < .05, **p < .01.

Figure 5. (A) CLSM micrographs of stained MC3T3-E1 cells showing morphology adhered on PEGDA/TCS, PEGDA/TCS/HNTs and PEGDA/TCS/T-HNTs hydrogels after 1, 3, and 7 days of culture (cytoskeleton and nucleus were stained with rhodamine-conjugated phalloidin (red) and DAPI (blue), respectively, and the scale bar is 50 µm); (B) the corresponding results of MC3T3-E1 cells. The values are represented as mean ± SD (n = 6). *p < .05, **p < .01.

Figure 6. (A) Release curves of BMP-2 peptide from PEGDA/TCS, PEGDA/TCS/HNTs and PEGDA/TCS/T-HNTs hydrogels and (B) the corresponding drug loading capacity (black) and drug encapsulation efficiency (red) of samples.

Figure 6. (A) Release curves of BMP-2 peptide from PEGDA/TCS, PEGDA/TCS/HNTs and PEGDA/TCS/T-HNTs hydrogels and (B) the corresponding drug loading capacity (black) and drug encapsulation efficiency (red) of samples.

Figure 7. ARS and ALP staining (A) and semi-quantitative analysis of ALP (B) and ARS (C) at day 7. All data represent averages from three independent experiments. The values are represented as mean ± SD (n = 6). The significance of differences from control groups is *p < .05, **p < .01.

Figure 7. ARS and ALP staining (A) and semi-quantitative analysis of ALP (B) and ARS (C) at day 7. All data represent averages from three independent experiments. The values are represented as mean ± SD (n = 6). The significance of differences from control groups is *p < .05, **p < .01.

Figure 8. The HE (A) and Masson (B) staining observations of bone regeneration in cranial bone defects in rats at 1, 2, and 3 months. The scale bar is 1 mm. The black arrow represents mature bone, blue arrow represents new-born bone, yellow colour represents residual hydrogel, yellow oval represents marrow cavity, blue oval represents blood capillary, green oval represents fibrous tissue.

Figure 8. The HE (A) and Masson (B) staining observations of bone regeneration in cranial bone defects in rats at 1, 2, and 3 months. The scale bar is 1 mm. The black arrow represents mature bone, blue arrow represents new-born bone, yellow colour represents residual hydrogel, yellow oval represents marrow cavity, blue oval represents blood capillary, green oval represents fibrous tissue.

Figure 9. The immunohistochemical BMP-2, OCN and CD31 examinations of the osteogenic potential of the hydrogels were performed at 3 month for control, PEGDA/TCS, PEGDA/TCS/T-HNTs and PEGDA/TCS/T-HNTs/BMP-2 groups, respectively. The scale bar is 100 μm. The red ovals represent BMP2 proteins, green arrows represent OCN proteins, blue arrows represent CD31 proteins.

Figure 9. The immunohistochemical BMP-2, OCN and CD31 examinations of the osteogenic potential of the hydrogels were performed at 3 month for control, PEGDA/TCS, PEGDA/TCS/T-HNTs and PEGDA/TCS/T-HNTs/BMP-2 groups, respectively. The scale bar is 100 μm. The red ovals represent BMP2 proteins, green arrows represent OCN proteins, blue arrows represent CD31 proteins.
Supplemental material

Supplementary_material.docx

Download MS Word (155.8 KB)